Literature DB >> 20457560

Using mice to examine p53 functions in cancer, aging, and longevity.

Lawrence A Donehower1.   

Abstract

The p53 tumor suppressor is a multifaceted transcription factor that responds to a diverse array of stresses that include DNA damage and aberrant oncogene signaling. On activation, p53 prevents the emergence of cancer cells by initiating cell cycle arrest, senescence (terminal cell cycle arrest), or apoptosis. Although its role in assuring longevity by suppressing cancer is well established, recent studies obtained largely from genetically engineered mouse models suggest that p53 may regulate longevity and aging. In some contexts, it appears that altered p53 activity may enhance longevity, and in others, it appears to suppress longevity and accelerate aging phenotypes. Here, we discuss how genetically engineered mouse models have been used to explore antiproliferative functions of p53 in cancer suppression and how mouse models with altered aging phenotypes have shed light on how p53 might influence the aging process.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20457560      PMCID: PMC2882127          DOI: 10.1101/cshperspect.a001081

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Biol        ISSN: 1943-0264            Impact factor:   10.005


  132 in total

1.  Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage.

Authors:  N H Chehab; A Malikzay; E S Stavridi; T D Halazonetis
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

Review 2.  ATM and related protein kinases: safeguarding genome integrity.

Authors:  Yosef Shiloh
Journal:  Nat Rev Cancer       Date:  2003-03       Impact factor: 60.716

3.  Anti-aging activity of the Ink4/Arf locus.

Authors:  Ander Matheu; Antonio Maraver; Manuel Collado; Isabel Garcia-Cao; Marta Cañamero; Consuelo Borras; Juana M Flores; Peter Klatt; Jose Viña; Manuel Serrano
Journal:  Aging Cell       Date:  2009-04       Impact factor: 9.304

Review 4.  Cancer and ageing: rival demons?

Authors:  Judith Campisi
Journal:  Nat Rev Cancer       Date:  2003-05       Impact factor: 60.716

Review 5.  Engineering cancer resistance in mice.

Authors:  Peter Klatt; Manuel Serrano
Journal:  Carcinogenesis       Date:  2003-05       Impact factor: 4.944

6.  Altered senescence, apoptosis, and DNA damage response in a mutant p53 model of accelerated aging.

Authors:  George W Hinkal; Catherine E Gatza; Neha Parikh; Lawrence A Donehower
Journal:  Mech Ageing Dev       Date:  2009-04       Impact factor: 5.432

7.  Regenerative capacity of neural precursors in the adult mammalian brain is under the control of p53.

Authors:  Silvia Medrano; Melissa Burns-Cusato; Marybless B Atienza; Donya Rahimi; Heidi Scrable
Journal:  Neurobiol Aging       Date:  2007-09-11       Impact factor: 4.673

8.  Telomerase reverse transcriptase delays aging in cancer-resistant mice.

Authors:  Antonia Tomás-Loba; Ignacio Flores; Pablo J Fernández-Marcos; María L Cayuela; Antonio Maraver; Agueda Tejera; Consuelo Borrás; Ander Matheu; Peter Klatt; Juana M Flores; José Viña; Manuel Serrano; Maria A Blasco
Journal:  Cell       Date:  2008-11-14       Impact factor: 41.582

9.  Expansion of hematopoietic stem cell phenotype and activity in Trp53-null mice.

Authors:  Michael TeKippe; David E Harrison; Jichun Chen
Journal:  Exp Hematol       Date:  2003-06       Impact factor: 3.084

10.  Distinct thresholds govern Myc's biological output in vivo.

Authors:  Daniel J Murphy; Melissa R Junttila; Laurent Pouyet; Anthony Karnezis; Ksenya Shchors; Duyen A Bui; Lamorna Brown-Swigart; Leisa Johnson; Gerard I Evan
Journal:  Cancer Cell       Date:  2008-12-09       Impact factor: 31.743

View more
  28 in total

Review 1.  Mouse models of p53 functions.

Authors:  Guillermina Lozano
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-09       Impact factor: 10.005

2.  The Regulation of Aging and Longevity: A New and Complex Role of p53.

Authors:  Zhaohui Feng; Meihua Lin; Rui Wu
Journal:  Genes Cancer       Date:  2011-04

Review 3.  Senescence regulation by the p53 protein family.

Authors:  Yingjuan Qian; Xinbin Chen
Journal:  Methods Mol Biol       Date:  2013

Review 4.  The ageing haematopoietic stem cell compartment.

Authors:  Hartmut Geiger; Gerald de Haan; M Carolina Florian
Journal:  Nat Rev Immunol       Date:  2013-04-15       Impact factor: 53.106

5.  SnoN activates p53 directly to regulate aging and tumorigenesis.

Authors:  Deng Pan; Qingwei Zhu; Michael J Conboy; Irina M Conboy; Kunxin Luo
Journal:  Aging Cell       Date:  2012-08-27       Impact factor: 9.304

6.  α-catenin is a tumor suppressor that controls cell accumulation by regulating the localization and activity of the transcriptional coactivator Yap1.

Authors:  Mark R Silvis; Bridget T Kreger; Wen-Hui Lien; Olga Klezovitch; G Marianna Rudakova; Fernando D Camargo; Dan M Lantz; John T Seykora; Valeri Vasioukhin
Journal:  Sci Signal       Date:  2011-05-24       Impact factor: 8.192

7.  Dysfunction of the MDM2/p53 axis is linked to premature aging.

Authors:  Davor Lessel; Danyi Wu; Carlos Trujillo; Thomas Ramezani; Ivana Lessel; Mohammad K Alwasiyah; Bidisha Saha; Fuki M Hisama; Katrin Rading; Ingrid Goebel; Petra Schütz; Günter Speit; Josef Högel; Holger Thiele; Gudrun Nürnberg; Peter Nürnberg; Matthias Hammerschmidt; Yan Zhu; David R Tong; Chen Katz; George M Martin; Junko Oshima; Carol Prives; Christian Kubisch
Journal:  J Clin Invest       Date:  2017-08-28       Impact factor: 14.808

8.  Using Mouse Models to Explore MDM-p53 Signaling in Development, Cell Growth, and Tumorigenesis.

Authors:  Hugh S Gannon; Stephen N Jones
Journal:  Genes Cancer       Date:  2012-03

9.  The Regulation of Multiple p53 Stress Responses is Mediated through MDM2.

Authors:  Wenwei Hu; Zhaohui Feng; Arnold J Levine
Journal:  Genes Cancer       Date:  2012-03

10.  Prolactin cooperates with loss of p53 to promote claudin-low mammary carcinomas.

Authors:  K A O'Leary; D E Rugowski; R Sullivan; L A Schuler
Journal:  Oncogene       Date:  2013-07-22       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.